Peripheral Neuropathy: Clinical Trials

1 trial for Peripheral Neuropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Peripheral Neuropathy: new trials by email Literature Review of Peripheral Neuropathy trials Research Report on Peripheral Neuropathy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IVIg for Demyelination in Diabetes Mellitus
10% intravenous immunoglobulin (IVIg), 0.9% sodium chloride - Peripheral Neuropathy, Diabetes Mellitus
Phase 4UnknownUniversity of Toronto252015-02-012016-11-11

Narrower conditions

Diabetes Mellitus (1)  ·  Peripheral Nervous System Diseases (1)  ·  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)

Broader conditions

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Chronic Disease (1)  ·  Demyelinating Diseases (1)  ·  Disease Attributes (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Immune System Diseases (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Polyneuropathies (1)

Interventions

Immunoglobulins, Intravenous (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)

Sponsors

University of Toronto (1)

Countries

Canada (1)

Top investigators

Ari Breiner, MD, FRCPC (1)